Healthtech Startups
16,794 companies tagged Healthtech, with their investors and founders.
Kindred provides integrated virtual and in-clinic health services for women, including doctor consultations, counseling, and bundled health management packages for conditions like PCOS, STI, and infertility. The platform operates as a collaborative care model offering comprehensive treatment plans in a judgment-free environment.
3 investors
Kingdom Supercultures develops functional health ingredients using natural microbes, aiming to improve consumer health. Its team combines microbiologists, data scientists, and industry professionals working on microbe-based ingredients.
3 investors
Kira Pharmaceuticals develops therapies targeting the complement system for patients with complement-mediated autoimmune and inflammatory diseases across areas including hematology, nephrology, neurology, dermatology and ophthalmology. It uses a proprietary LOGIC drug discovery platform and has a lead asset entering Phase 2 alongside additional pipeline assets.
3 investors
KiraGen Bio develops gene-edited, donor-derived cell therapies designed to resist tumor microenvironment suppression and maintain durable function. Its platform focuses on combining multiple gene edits to produce scalable, allogeneic cell therapy candidates.
3 investors
Kivo Health provides AI-powered virtual rehabilitation and care programs for patients with chronic obstructive pulmonary disease (COPD), covered by insurance, designed to improve symptoms and reduce hospitalizations.
3 investors
Healthcare company that raised a $24M Series A
3 investors
Klinik Pintar operates a network of standardized clinics in Indonesia and provides clinic management software, pharmaceutical procurement services, and operational support to healthcare facilities.
3 investors
Kobiolabs (κ³ λ°μ΄μ€λ©) develops microbiome-based drugs using its Smartiome platform, which applies AI-driven microbiome multi-omics analysis and a microbial library for drug discovery. The company focuses on immune, metabolic, and brain/neurological diseases, and uses a biofoundry-based microbe drug delivery system (mDDS).
3 investors
Koda provides digital tools for patients and healthcare providers to facilitate complex healthcare discussions and advance care planning, converting conversations into actionable plans.
3 investors
Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology. It aims to create genetic medicines for patients with rare and highly prevalent debilitating or life-threatening diseases.
3 investors
Kry is a digital healthcare provider offering remote consultations via app and in-person visits at physical clinics across Sweden. The platform serves patients seeking medical advice, prescriptions, and ongoing care coordination for acute and chronic conditions.
3 investors
Kubanda develops innovative healthcare solutions for pets, focusing on pet wellness.
3 investors
Kyra is an ICHRA (Individual Coverage Health Reimbursement Arrangement) platform that handles contribution modeling, quoting, enrollment, compliance, and year-round benefits support for employers, brokers, and employees. It uses employees' actual medical, provider, and prescription data to match them with health plans and provides ongoing personalized benefits advocacy.
3 investors
Kyruus Health provides a healthcare access platform that unifies provider and member data to help patients find, schedule, and access care. It serves health plans, health systems, and provider organizations across the United States, offering tools for care search, scheduling, and provider data management.
3 investors
Lamar Health provides workflow automation software for specialty pharmacies and infusion organizations, enabling teams to manage prior authorization processes and patient access workflows. The platform integrates with existing pharmacy and EHR systems to reduce manual work, delays, and denials while improving staff efficiency and patient treatment initiation times.
3 investors
Landsdowne Labs develops button battery technology that deactivates batteries after accidental ingestion to address health risks. The company commercializes advanced material science solutions for global manufacturers.
3 investors
New Lantern builds software for radiologists that consolidates workflow across multiple systemsβworklist management, image viewing, and reportingβto reduce administrative overhead and let radiologists focus on reading studies and making diagnoses. The platform includes an AI assistant called Curie that learns individual radiologist reporting styles to draft reports automatically.
3 investors
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation. The company is a medical device developer based in the United States.
3 investors
Lasarrus is developing WearME, a multimodal wearable system that continuously monitors six vital signs to detect COPD exacerbations early, giving clinicians up to 48 hours of advance warning. The remote patient monitoring system is aimed at healthcare providers and clinical staff managing patients with chronic obstructive pulmonary disease.
3 investors
Lassie provides software for doctors' offices to automate administrative tasks and office management. The company serves medical practices and is positioned in the healthcare technology sector.
3 investors
LAVA develops the Gammabody platform, which generates bispecific antibodies that activate gamma-delta T cells to treat cancer by directing immune cells to tumors and triggering anti-cancer immune responses.
3 investors
Lavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.
3 investors
Layer Health builds AI tools for hospitals and health systems that automate clinical registry abstraction and custom quality-metric extraction across service lines such as cardiovascular, surgery, and oncology. Its platform also supports clinical guidance, including guideline-aligned care pathways and site-of-care optimization by reasoning over the full clinical record.
3 investors
A clinical-stage biopharmaceutical company developing small molecule therapies for schizophrenia, bipolar depression, and other neuropsychiatric disorders. Its lead candidate, LB-102, is an oral benzamide antipsychotic being developed for the U.S. market.
3 investors